1. Home
  2. OBIO vs TIRX Comparison

OBIO vs TIRX Comparison

Compare OBIO & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • TIRX
  • Stock Information
  • Founded
  • OBIO 2017
  • TIRX 2010
  • Country
  • OBIO United States
  • TIRX China
  • Employees
  • OBIO N/A
  • TIRX N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • TIRX Specialty Insurers
  • Sector
  • OBIO Health Care
  • TIRX Finance
  • Exchange
  • OBIO Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • OBIO 118.8M
  • TIRX 118.4M
  • IPO Year
  • OBIO N/A
  • TIRX 2021
  • Fundamental
  • Price
  • OBIO $2.57
  • TIRX $0.80
  • Analyst Decision
  • OBIO Strong Buy
  • TIRX
  • Analyst Count
  • OBIO 4
  • TIRX 0
  • Target Price
  • OBIO $14.00
  • TIRX N/A
  • AVG Volume (30 Days)
  • OBIO 403.6K
  • TIRX 64.7K
  • Earning Date
  • OBIO 08-12-2025
  • TIRX 08-26-2025
  • Dividend Yield
  • OBIO N/A
  • TIRX N/A
  • EPS Growth
  • OBIO N/A
  • TIRX N/A
  • EPS
  • OBIO N/A
  • TIRX N/A
  • Revenue
  • OBIO $2,944,000.00
  • TIRX N/A
  • Revenue This Year
  • OBIO $20.47
  • TIRX N/A
  • Revenue Next Year
  • OBIO $11.45
  • TIRX N/A
  • P/E Ratio
  • OBIO N/A
  • TIRX N/A
  • Revenue Growth
  • OBIO 41.61
  • TIRX 158.74
  • 52 Week Low
  • OBIO $2.37
  • TIRX $0.80
  • 52 Week High
  • OBIO $7.04
  • TIRX $2.65
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 40.46
  • TIRX 21.54
  • Support Level
  • OBIO $2.50
  • TIRX $0.90
  • Resistance Level
  • OBIO $2.75
  • TIRX $0.98
  • Average True Range (ATR)
  • OBIO 0.18
  • TIRX 0.07
  • MACD
  • OBIO -0.03
  • TIRX -0.01
  • Stochastic Oscillator
  • OBIO 11.47
  • TIRX 0.00

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: